| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |